As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Announcing the launch of In Review
Research Integrity and Peer Review, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Aims and scope
Research Integrity and Peer Review is an international, open access, peer reviewed journal that encompasses all aspects of integrity in research publication, including peer review, study reporting, and research and publication ethics. Particular consideration is given to submissions that address current controversies and limitations in the field and offer potential solutions. We welcome research into peer review and editorial decision making, however reports of individual journal or publisher decisions or actions will not be considered.
Please click here for more information.
We are pleased to announce that all articles published in Research Integrity and Peer Review are included in PubMed, PubMed Central and DOAJ.
Research Integrity and Peer Review is endorsed by the following organizations:
The Enhancing the QUAlity and Transparency Of health Research (EQUATOR) Network works with all stakeholders, including researchers, medical journal editors, and funding bodies, to promote and support the complete and transparent reporting of all health research.
The International Society for Managing and Technical Editors (ISMTE) connects editorial office staff across all areas of academic and scholarly publishing, and work together to develop best practices, with a particular interest in publication ethics.
Stephanie Boughton, Editor-in-Chief (Research and publication ethics)
Stephanie Boughton is a Research Integrity Manager in the Springer Nature Research Integrity Group where she manages a team of Research Integrity Advisers. The team provides support and advice to in-house staff and external Editors across Springer Nature on dealing with publication ethics issues and ensuring adherence to editorial best practice and standards in peer review.
Stephanie has a degree in Medicine from Brighton and Sussex Medical School and previously worked in hospital clinical practice as a junior doctor. She joined BioMed Central in 2010 as Deputy Medical Editor and later became Medical Editor in BioMed Central’s Research Integrity Group before joining the newly formed Springer Nature Research Integrity Group.
Stephanie has conducted research and participated in many events relating to peer review, research integrity and publication ethics and has also developed guidelines for editors on dealing with cases of text recycling in conjunction with COPE.
Maria Kowalczuk, Editor-in-Chief (Research and publication ethics)
Maria Kowalczuk obtained a PhD in Bioinformatics and Genomics at the University of Wroclaw, Poland in 2002. She then took up a permanent position there researching the coding properties of microbial genomes. In 2006 Maria joined BioMed Central as an in-house Editor managing the peer review process for a number of BMC series biology journals, and the flagship journal BMC Biology in 2008. In 2010 Maria moved to the Biology and Medical Editors team responsible for the editorial oversight of the BMC series of journals. The role expanded in 2012 to cover all aspects of policy and ethical issues across all BioMed Central’s journals.
In 2014 Maria was appointed Biology Editor in BioMed Central’s Research Integrity Group. In 2017 the team was restructured and expanded to become Springer Nature Research Integrity Group. In her current role as Research Integrity Manager, Maria oversees a team of Research Integrity Advisers who support in-house staff and external Editors across Springer Nature in ensuring adherence to editorial best practice and standards in peer review. Maria also continues to pursue research into peer review and takes part in debates, meetings and conferences related to research integrity and publication ethics.
Joerg Meerpohl, Editor-in-Chief (Research reporting)
Joerg Meerpohl is a board-qualified pediatrician and pediatric hematologist & oncologist. He has been working as a researcher at the German Cochrane Centre since 2007 and was appointed deputy director in 2011 and co-director in 2015. His main research interests include systematic review methodology, transparency in research and related dissemination bias as well as reporting quality in particular. Since 2015, Joerg has been a member of the Cochrane Steering Group.
For many years Joerg has also been an active member of the GRADE working group, and has run many GRADE workshops at national and international organizations. Joerg worked as a GRADE methodology advisor with several WHO panels, the European Stroke Organization and the Robert Koch Institute in Germany amongst others. In 2013 he founded the GRADE center in Freiburg, Germany and is a member of the GRADE guidance committee.
Mario Malički, Editor-in-Chief (Peer review)
Mario Malički has obtained his MD at the University of Zagreb School of Medicine, Croatia, MA in Literature and Medicine at King’s College, London, UK, and PhD in Medical Ethics at the University of Split School of Medicine, Split, Croatia. He has been a member of Cochrane Croatia, and of the New Frontiers of Peer Review (PEERE) EU COST Action. His main research interest is meta-science, with the focus on peer review, research integrity, authorship and transparency in reporting. His other interest includes medical ethics, hope, statistics, speculative fiction, Frank Herbert’s opus and Leonard Cohen’s poetry.
His scholarly profile can be seen here, and his review experience at: https://publons.com/researcher/329329/mario-malicki/
Annual Journal Metrics
82 days to first decision for reviewed manuscripts only
68 days to first decision for all manuscripts
149 days from submission to acceptance
28 days from acceptance to publication